Effect and mechanism of transplantation of human umbilical cord mesenchymal stem cells with overexpression of the Numb gene in treatment of cholestatic liver fibrosis
- VernacularTitle:Numb基因过表达的人脐带间充质干细胞移植对胆汁淤积性肝纤维化的干预作用及其机制
- Author:
Shihao ZHANG
1
;
Changqing ZHAO
2
;
Mingyan YANG
1
;
Feifei XING
1
;
Wei LIU
1
;
Gaofeng CHEN
1
;
Jiamei CHEN
1
;
Ping LIU
1
;
Yongping MU
1
Author Information
- Publication Type:Journal Article
- Keywords: Hepatic Fibrosis; Numb Gene; Umbilical Cord Mesenchymal Stem Cell; Ductular Reaction; Numb-PTBL-p53-HNF4α axis
- From: Journal of Clinical Hepatology 2026;42(1):80-89
- CountryChina
- Language:Chinese
- Abstract: ObjectiveTo investigate the effect and mechanism of transplantation of human umbilical cord mesenchymal stem cell （hUC-MSC） with overexpression of the Numb gene in the treatment of cholestatic liver fibrosis （CLF）. MethodsThe technique of lentiviral transfection was used to induce the overexpression of the Numb gene in hUC-MSC （hUC-MSCNumb-OE）， and hUC-MSC transfected with empty vector （hUC-MSCOE-EV） was used as negative control. Bile duct ligation （BDL） was performed to establish a rat model of CLF， and then the rats were randomly divided into BDL group， hUC-MSC group， hUC-MSCOE-EV group， and hUC-MSCNumb-OE group， while a sham-operation group was also established. The rats in the intervention groups were given a single splenic injection of the corresponding cells after BDL， and samples were collected at the end of week 4. Related indicators were measured， including serum biochemistry， liver histopathology， the content of hydroxyproline （Hyp） in the liver， hepatic stellate cell activation， ductular reaction， liver regeneration， and the expression levels of key molecules in the Numb-p53 signaling axis. A one-way analysis of variance was used for comparison of continuous data between multiple groups， and the least significant difference t-test was used for further comparison between two groups. ResultsCompared with the BDL group， the hUC-MSC group and the hUC-MSCOE-EV group had significant reductions in the levels of serum biochemical parameters （aspartate aminotransferase， gamma-glutamyl transpeptidase， total bile acid， total bilirubin， and direct bilirubin）， liver fibrosis markers （the content of Hyp and the expression levels of alpha-smooth muscle actin， tumor necrosis factor-α， and transforming growth factor-beta 1）， and ductular reaction markers （the expression levels of CK7 and CK19） （all P <0.05）， and compared with the hUC-MSCOE-EV group， the hUC-MSCNumb-OE group had significantly greater improvements in the above indicators （all P <0.05）. In addition， compared with the hUC-MSCOE-EV group， the hUC-MSCNumb-OE group had significant improvements in the expression levels of liver regeneration-related markers （albumin and hepatocyte nuclear factor 4α） and the molecules associated with the Numb-p53 signaling axis （Numb， pNumb， Mdm2， and p53） （all P <0.05）. ConclusionOverexpression of the Numb gene can enhance the therapeutic effect of hUC-MSC on CLF， possibly by activating the Numb-PTBL-p53-HNF4α axis， promoting the hepatic differentiation of hUC-MSCs and subsequently enhancing liver regeneration.
